SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will present 14 studies at the Radiological Society ...

TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.

Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...

Discover Singapore's new initiatives in preventive medicine, including AI, genetic screening, and Medisave flexibility, to support a super-aged nation. Read more at straitstimes.com. Read more at ...

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

Tempus AI launched its HRD-RNA algorithm, an AI-driven model for identifying Homologous Recombination Deficiency in cancer patients. The company also partnered with Median Technologies to integrate ...

One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming and labor-intensive process called cytology. It involves visually inspecting ...

The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine ...

Making healthier choices is hard. But it’s also something that AI is uniquely positioned to solve, write Sam Altman and ...